Clinical Trial Details
EORTC-06012
Back to Clinical Trials Database
Gemtuzumab Ozogamycin (GO) combined with standard intensive chemotherapy versus standard intensive chemotherapy alone for induction/consolidation in patients 61 - 75 years old with previously untreated AML : a randomized phase III trial (AML-17) of the EORTC - LG and the GIMEMA-ALWP
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 25-Sep-2002 Date Step1 close: 13-Aug-2007 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 450 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00052299 |
| NCT number | NCT00052299 |
| EudraCT | 2005-001347-37 |
